Upcoming Events
Pharmaceutical / Medicinal
MAR
17
Verification and Validation - Product, Equipment/Process, Software and QMS Develop / review a company's Master Validation Plan for major cGMP deficiencies. Address the U.S. FDA's newer and tougher regulatory stance. One major failing is lack of sufficient or targeted risk-based V&V planning: Start with a Master Va...
17 - 18 Mar 2026
Online Event | United States
MAR
18
OPTC
OPT Congress 2026 OPT Congress 2026 is the leading industry event for scientists, directors, and technology providers driving innovation across oligonucleotide, mRNA, and peptide therapeutics. Now in its 11th year, this event provides a unique forum for translating...
18 - 19 Mar 2026
Boston, United States
MAR
19
SOP Writing, Training and Compliance in the Pharmaceutical Industry Recording of Live Virtual Seminar conducted on June 19-20, 2025 Complete this training at your own pace within 5 working days. The recording will be enabled on your convenient dates. Standard Operating Procedures (SOPs) are the basis for a lar...
19 - 20 Mar 2026
Online Event | United States
MAR
23
Change Control Best Practices - Avoiding Unintended Consequences of Changes One of the top 10 FDA 483 and Warning Letter citations is for inadequate change control. Change control receives detailed scrutiny during FDA inspections, and FDA reviews change control documentation to determine that changes did not adversely imp...
23 - 24 Mar 2026
Online Event | United States
MAR
24
VIPRY 2026
9th Annual Pharma Regulatory Summit 2026 9TH ANNUAL PHARMA REGULATORY SUMMIT 2026 “Driving Regulatory Excellence for a Changing Pharma Landscape” 24th March 2026, Hotel Kohinoor Continental, Mumbai, India The 9th Annual Pharma Regulatory Summit 2026 congregates foremost globa...
24 - 24 Mar 2026
Mumbai, India
MAR
26
Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions Raw material requirements in a cGMP environment are often overlooked as a Company develops new products. Depending upon the product being developed, e.g., tablets and capsules vs. biotechnology products to include recombinant microorganisms an...
26 - 27 Mar 2026
Online Event | United States
MAR
31
23rd Annual Strategic Alliance Management Congress As biopharmaceutical innovation becomes more collaborative and global, effective alliance management increasingly plays a decisive, business-critical role—transforming partnerships into powerful engines of progress. Now in its 23rd year &nda...
31 - 01 Apr 2026
Boston, United States
APR
16
Good Manufacturing Practices (GMP) Good Manufacturing Practices (GMP) describe the requirements for manufacturing drug product in each country or region and cover areas such as facility design and sanitation, product testing, product identification, equipment, packaging, warehousin...
16 - 17 Apr 2026
Online Event | United States

Aug
27

A Review of the Latest Prevention and Treatment Strategies For COVID-19

 
 Seminar/trade show (noCPF)

When:

  27 Aug 2020

Where:

  Online Event

Website URL:

  https://www.complianceonline.com/covid-prevention-treatment-webinar-training-706536-prdw?channel=brownwalker

Sponsoring organization:

  Compliance Online

Categories:

  Medicine & Health - Pharmaceutical / Medicinal

Keywords:


Event description:

There is a lot of confusion around what will happen to individuals, what this new enemy is that has suddenly appeared in our midst, interrupted/threatened our lives and what to do to stay safe. The goal of this webinar it to provide clear information and provide an update to the latest prevention and treatment strategies for COVID-19. The Coronaviruses (CoV) are positive sense RNA viruses possessing spike-like projections on the surface creating a crown-like appearance upon magnification with electron microscopy. They are a large family of viruses causing a wide range of illness from the common cold to more severe diseases, such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). The novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a man-made chimera that was engineered in 2015 in the University of North Carolina at Chapel Hill. This engineered virus claimed its first victim ... Read more

Posting date:

09 August 2020  |  513 views

Placement:

Not-featured (How do I make my event featured?)